Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “Umbilicals”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3
All sourcesNASA NTRSDOE OSTI
NASA NTRS1991

Orbiter Umbilical Hinge Door Problem

During processing work on the orbiter Discovery at Pad A, significant cracks were found on all four lug hinges on the two external tank umbilical door drive mechanisms. NASA managers opted to roll back the vehicle to the Vehicle Assembly Building (VAB) on March 7, and then to the Orbiter Processing Facility (OPF) for repair. Hinges were replaced with units taken from orbiter COLUMBIA, and reinforced. Discovery returned to the pad on April 1. Shown are the cracked orbiter umbilical door hinges.

Source record↗
NASA NTRS2013

Development of the Orion Crew-Service Module Umbilical Retention and Release Mechanism

The Orion Crew-Service Module umbilical retention and release mechanism supports, protects and disconnects all of the cross-module commodities between the spacecraft's crew and service modules. These commodities include explosive transfer lines, wiring for power and data, and flexible hoses for ground purge and life support systems. Initial development testing of the mechanism's separation interface resulted in binding failures due to connector misalignments. The separation interface was redesigned with a robust linear guide system, and the connector separation and boom deployment were separated into two discretely sequenced events. Subsequent analysis and testing verified that the design changes corrected the binding. This umbilical separation design will be used on Exploration Flight Test 1 (EFT-1) as well as all future Orion flights. The design is highly modular and can easily be adapted to other vehicles/modules and alternate commodity sets.

Delap, Damon↗
NASA NTRSDate not supplied

A Flexible Multibody Approach to Space Launch System Liftoff Pad Separation with Umbilical Disconnect

A flexible multibody dynamic framework is applied to the Space Launch System (SLS) liftoff Coupled Loads Analysis (CLA), enabling computational efficiencies and systematic inclusion of components and various nonlinearities. The objective of this work is to simulate the SLS liftoff transient pad separation event inclusive of umbilical disconnects. The vehicle stacking preloads and cryogenically induced preloads, due to the fueling of the Core Stage (CS), are integrated via specialized deformed coupling procedure to ensure full capture of the liftoff transient event. The Vehicle Stabilizer System (VSS) hydraulic struts are nonlinear and provide amplitude dependent damping, significantly contributing to the liftoff transient event. Ground Extensible Columns (EC) provide additional stiffness and preloads on the Mobile Launcher (ML), also significantly contributing to the liftoff transient. An advanced Henkel-Mar algorithm, with separation and re-contact, thus tracking the potential post separation re-contact between the booster aft skirt and ML, the umbilicals and vehicle, and ground EC separation. For this system level nonlinear dynamic simulation, the flexible multibody framework provides a systematic approach for the addition of component specific algorithms to enforce nonlinearities. This multibody framework is similar to an object-oriented programming language integrating classes of associated subroutines. As such, the complexities associated with the nonlinear CLA are greatly reduced, facilitating simplified bookkeeping as well as accelerating the execution of the nonlinear time-domain simulations.

Joel W Sills Jr.↗
NASA NTRS2001

Regulation of PGE(2) and PGI(2) release from human umbilical vein endothelial cells by actin cytoskeleton

Disruption of microfilaments in human umbilical vein endothelial cells (HUVEC) with cytochalasin D (cytD) or latrunculin A (latA) resulted in a 3.3- to 5.7-fold increase in total synthesis of prostaglandin E(2) (PGE(2)) and a 3.4- to 6.5-fold increase in prostacyclin (PGI(2)) compared with control cells. Disruption of the microtubule network with nocodazole or colchicine increased synthesis of PGE(2) 1.7- to 1.9-fold and PGI(2) 1.9- to 2.0-fold compared with control cells. Interestingly, however, increased release of PGE(2) and PGI(2) from HUVEC into the media occurred only when microfilaments were disrupted. CytD treatment resulted in 6.7-fold more PGE(2) and 3.8-fold more PGI(2) released from HUVEC compared with control cells; latA treatment resulted in 17.7-fold more PGE(2) and 11.2-fold more PGI(2) released compared with control cells. Both increased synthesis and release of prostaglandins in response to all drug treatments were completely inhibited by NS-398, a specific inhibitor of cyclooxygenase-2 (COX-2). Disruption of either microfilaments using cytD or latA or of microtubules using nocodazole or colchicine resulted in a significant increase in COX-2 protein levels, suggesting that the increased synthesis of prostaglandins in response to drug treatments may result from increased activity of COX-2. These results, together with studies demonstrating a vasoprotective role for prostaglandins, suggest that the cytoskeleton plays an important role in maintenance of endothelial barrier function by regulating prostaglandin synthesis and release from HUVEC.

Non-NASA Center↗
DOE OSTI2021

Development of an optimized and scalable method for isolation of umbilical cord blood-derived small extracellular vesicles for future clinical use

Abstract Extracellular vesicles (EV) are a promising therapeutic tool in regenerative medicine. These particles were shown to accelerate wound healing, through delivery of regenerative mediators, such as microRNAs. Herein we describe an optimized and upscalable process for the isolation of EV smaller than 200 nm (sEV), secreted by umbilical cord blood mononuclear cells (UCB-MNC) under ischemic conditions and propose quality control thresholds for the isolated vesicles, based on the thorough characterization of their protein, lipid and RNA content. Ultrafiltration and size exclusion chromatography (UF/SEC) optimized methodology proved superior to traditional ultracentrifugation (UC), regarding production time, standardization, scalability, and vesicle yield. Using UF/SEC, we were able to recover approximately 400 times more sEV per mL of media than with UC, and upscaling this process further increases EV yield by about 3-fold. UF/SEC-isolated sEV display many of the sEV/exosomes classical markers and are enriched in molecules with anti-inflammatory and regenerative capacity, such as hemopexin and miR-150. Accordingly, treatment with sEV promotes angiogenesis and extracellular matrix remodeling, in vitro. In vivo, UCB-MNC-sEV significantly accelerate skin regeneration in a mouse model of delayed wound healing. The proposed isolation protocol constitutes a significant improvement compared to UC, the gold-standard in the field. Isolated sEV maintain their regenerative properties, whereas downstream contaminants are minimized. The use of UF/SEC allows for the standardization and upscalability required for mass production of sEV to be used in a clinical setting.

Cardoso, Renato M. S.↗
DOE OSTI2021

Human umbilical cord mesenchymal stem cells regulate CD54 and CD105 in vascular endothelial cells and suppress inflammation in Kawasaki disease

Highlights: • CD31{sup +}CD54{sup +} and CD31{sup +}CD105{sup +} EMPs change inconsistently at different stages of KD, potentially reflect endothelial function. • HucMSCs suppress inflammation and regulate the expression levels of CD54 and CD105 in vascular endothelial cells in KD. • HucMSCs inhibit coronary artery inflammation while also promoting the repair of damaged tissues in KD mice. The objective was to evaluate the expression levels of CD31{sup +}CD54{sup +} and CD31{sup +}CD105{sup +} endothelial microparticles (EMPs) before and after intravenous immunoglobulin (IVIG) treatment of Kawasaki disease (KD). To explore the role of human umbilical cord mesenchymal stem cells (hucMSCs) in inhibiting endothelial inflammation in KD, the effects of hucMSCs on the expression of CD54 and CD105 in endothelial cells in KD were analyzed in vivo and in vitro.

60 APPLIED LIFE SCIENCES↗